A novel interstitial deletion of 3p in essential thrombocythemia [2]

Cancer Genetics and Cytogenetics

Volumn 153, Issue 1, 2004, Pages 84-85

  Wong, K F ^a  

^a QUEEN ELIZABETH HOSPITAL   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYUREA;

ACUTE HEART INFARCTION; AGED; CARDIOGENIC SHOCK; CASE REPORT; CHROMOSOME 3P; CYTOGENETICS; DIAGNOSTIC PROCEDURE; FEMALE; GENE DELETION; HUMAN; KARYOTYPING; LABORATORY TEST; LETTER; PRIORITY JOURNAL; THROMBOCYTOSIS; THROMBOTIC THROMBOCYTOPENIC PURPURA; CHROMOSOME 3; CHROMOSOME DELETION; GENETICS; HEART INFARCTION; THROMBOCYTHEMIA; ULTRASTRUCTURE;

PURPURA;

AGED; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 3; FEMALE; HUMANS; KARYOTYPING; MYOCARDIAL INFARCTION; THROMBOCYTHEMIA, HEMORRHAGIC;

EID: 4644338239     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2003.12.008     Document Type: Letter

References (9)

1. Mitelman F, Johansson B, Mertens F, editors. Mitelman database of chromosome aberrations in cancer [Internet]. Updated August 20, 2003. Available at: http://cgap.nci.nih.gov/Chromosomes/Mitelman.
2. Imbert M., Pierre R., Thiele J., Vardiman J.W., Brunning R.D., Flandrin G. Essential thrombocythaemia. Jaffe E.S., Harris N.L., Stein H., Vardiman J.W. Pathology and genetics of tumours of the haematopoietic and lymphoid tissues. World Health Organization Classification of Tumours. 2001;39-41 IARC Press, Lyon
3. Secker-Walker L.M., Mehta A., Bain B. Abnormalities of 3q21 and 3q26 in myeloid malignancy: a United Kingdom Cancer Cytogenetic Group study. Br J Haematol. 91:1995;490-501
4. Jenkins R.B., Tefferi A., Solberg L.A. Jr., Dewald G.W. Acute leukemia with abnormal thrombopoiesis and inversions of chromosome 3. Cancer Genet Cytogenet. 39:1989;167-179
5. Vardiman J.W., Pierre R., Thiele J., Imbert M., Brunning R.D., Flandrin G. Chronic myelogenous leukaemia. Jaffe E.S., Harris N.L., Stein H., Vardiman J.W. Pathology and genetics of tumours of the haematopoietic and lymphoid tissues. World Health Organization Classification of Tumours. 2001;20-26 IARC Press, Lyon
6. Johansson B., Billstrom R., Kristoffersson U., Akerman M., Garwicz S., Ahlgren T., Malm C., Mitelman F. Deletion of chromosome arm 3p in hematologic malignancies. Leukemia. 11:1997;1207-1213
7. Shi G., Weh H.J., Martensen S., Seeger D., Hossfeld D.K. 3p21 is a recurrent treatment-related breakpoint in myelodysplastic syndrome and acute myeloid leukemia. Cytogenet Cell Genet. 74:1996;295-299
8. Whang-Peng J., Lee E.C., Minna J.D., Abeloff M.D., Bradley E.C., Young R.C., Longo D.L. Deletion of 3(p14p23) in secondary erythroleukemia arising in long-term survivors of small cell lung cancer. J Natl Cancer Inst. 80:1988;1253-1255
9. Lindquist R., Forsblom A.M., Ost A., Gahrton G. Mutagen exposures and chromosome 3 aberrations in acute myelocytic leukemia. Leukemia. 14:2000;112-118